Published in
Elsevier, The Lancet Oncology, 7(16), p. 746-748
DOI: 10.1016/s1470-2045(15)00028-5
Links
Tools
EGFR mutations and EGFR tyrosine kinase inhibitors
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 